Biotech Industry
The Latest
-
AbbVie Signs Exclusive Licensing Deal With Sirona Biochem For Breakthrough Compound
AbbVie acquired the license to commercialize and market Sirona’s TFC-1067 compound as part of its expansion into the cosmetics space. 
AbbVie acquired the license to commercialize and market Sirona’s TFC-1067 compound as part of its expansion into the cosmetics space. -
Nasdaq-Listed BeiGene To Be A Star On The Shanghai Board
The offering is expected in the first half of next year. It will be the world's first pharmaceutical firm to be listed on three stock exchanges. 
The offering is expected in the first half of next year. It will be the world's first pharmaceutical firm to be listed on three stock exchanges. -
Eli Lilly Stock Price Jumps After It Requested FDA Approval For Its COVID-19 Treatment
The treatment has reportedly proven effective in reducing COVID-19 symptoms that resulted in patients being hospitalized. 
The treatment has reportedly proven effective in reducing COVID-19 symptoms that resulted in patients being hospitalized. -
Genor Biopharma Says It Will Make Cheaper Breast Cancer Drugs Than Competitors
Genor Biopharma's drug will compete with offerings from Swiss biotechnology company Roche and Britain's GSK. 
Genor Biopharma's drug will compete with offerings from Swiss biotechnology company Roche and Britain's GSK. -
CStone Shares Skyrocket Following $480 Million Pfizer Deal
CStone Pharmaceuticals stock price jumped by as much as 40 percent after it announced a deal with Pfizer worth an estimated $480 million. 
CStone Pharmaceuticals stock price jumped by as much as 40 percent after it announced a deal with Pfizer worth an estimated $480 million. -
Shanghai Henlius Biotech Pushing Ahead With Star Market Listing
Shanghai Henlius Biotech revealed that it was making a lot of progress toward its eventual listing on Shanghai's NASDAQ-style Star Market. 
Shanghai Henlius Biotech revealed that it was making a lot of progress toward its eventual listing on Shanghai's NASDAQ-style Star Market. -
BioMarin Pharmaceuticals' Stock Price Falls After FDA Rejects Treatment Application
BioMarin Pharmaceuticals' shares fell more than 31 percent Wednesday after the FDA called for more data about its hemophilia therapy. 
BioMarin Pharmaceuticals' shares fell more than 31 percent Wednesday after the FDA called for more data about its hemophilia therapy. -
AstraZeneca To Supply Europe With Newly Developed Covid-19 Vaccine
AstraZeneca has reached an agreement with the Inclusive Vaccine Alliance, a group formed by EU-member countries, to supply it with up to 400 million doses of its newly developed coronavirus vaccine. 
AstraZeneca has reached an agreement with the Inclusive Vaccine Alliance, a group formed by EU-member countries, to supply it with up to 400 million doses of its newly developed coronavirus vaccine. -
AstraZeneca Said To Be In Talks With Gilead Over Possible Merger
British-Swedish biotech firm AstraZeneca reportedly approached Gilead Sciences last month, proposing a possible merger deal. 
British-Swedish biotech firm AstraZeneca reportedly approached Gilead Sciences last month, proposing a possible merger deal. -
Hong-Based Firm Pacific GeneTech Developing Swine Fever Vaccine
Pacific GeneTech is co-developing a potential African swine fever vaccine with US-based biotech firm EpiVax along with 15 other institutions worldwide. 
Pacific GeneTech is co-developing a potential African swine fever vaccine with US-based biotech firm EpiVax along with 15 other institutions worldwide.
